| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |